Gore Gets FDA Approval for Tigris Vascular Stent

Gore has received premarket approval from the FDA for its Tigris vascular stent.

The device features a combination of flexible fluoropolymer and single-wire nitinol and is designed to adapt to the natural movement of the knee, the company said.

Study data on the product showed a 0 percent rate of fractures versus the 27 percent from the control arm. — Cynthia Jessup